Globrands AI Stock Analysis
Want to see IL:GLRS full AI Analyst Report?
Globrands (GLRS) AI Stock Analysis
Globrands
(TASE:GLRS)
Globrands's stock score is weighed down primarily by severe weaknesses in financial health—escalating leverage, negative cash flows, and deteriorating margins are major risks that threaten sustainability. Technical conditions reinforce near-term weakness, although valuation appears superficially attractive due to a low P/E and high yield. However, the ability to maintain future payouts and profitability is questionable unless operational trends stabilize.
Globrands (GLRS) vs. iShares MSCI Israel ETF (EIS)
- Market Cap
- ILS 129.02M
- Dividend Yield
- 31.11%
- Average Volume (3M)
- 1,108
- Price to Earnings (P/E)
- 2.2
- Beta (1Y)
- 0.91
- Revenue Growth
- 6.09%
- EPS Growth
- -13.79%
- Country
- Israel
- Employees
- 360
- Sector
- General
- Sector Strength
- 55
- Industry
- Tobacco
Globrands Business Overview & Revenue Model
Company Description
Globrands Ltd. is an Israeli enterprise primarily engaged in the importation, distribution, marketing, and sale of tobacco, food, and confectionery products across the country. Its business operations are segmented into two key divisions: Smoking Pro...
How the Company Makes Money
Globrands makes money through a diversified revenue model that includes the sale of consumer goods across multiple retail channels, such as supermarkets, online marketplaces, and direct-to-consumer platforms. Key revenue streams include product sales...
Globrands Financial Statement Overview
Summary
Globrands's financial performance is weak: profitability has deteriorated with declining revenue (-1.5% TTM), and margins are shrinking. The balance sheet is highly leveraged (Debt/Equity: 4.2), raising solvency risk, and recent cash flows are negative and volatile, highlighting significant quality-of-earnings and liquidity concerns.
Income Statement
49NeutralBalance Sheet
28NegativeCash Flow
24Negative| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 811.27M | 784.89M | 753.78M | 664.83M | 596.02M | 549.10M |
| Gross Profit | 236.57M | 237.72M | 228.67M | 197.17M | 193.47M | 183.56M |
| EBITDA | 118.14M | 110.64M | 122.75M | 101.22M | 106.63M | 109.08M |
| Net Income | 60.13M | 59.19M | 74.10M | 59.46M | 70.27M | 72.74M |
Balance Sheet | ||||||
| Total Assets | 586.07M | 645.94M | 576.14M | 493.53M | 427.24M | 269.05M |
| Cash, Cash Equivalents and Short-Term Investments | 17.69M | 12.29M | 11.11M | 11.58M | 13.41M | 13.92M |
| Total Debt | 284.38M | 403.13M | 378.21M | 318.86M | 336.75M | 188.71M |
| Total Liabilities | 476.20M | 570.15M | 514.86M | 445.76M | 371.68M | 213.44M |
| Stockholders Equity | 111.25M | 77.83M | 76.52M | 57.62M | 58.41M | 55.62M |
Cash Flow | ||||||
| Free Cash Flow | 104.08M | 48.90M | 9.07M | 16.50M | -55.68M | 75.60M |
| Operating Cash Flow | 110.24M | 59.52M | 26.23M | 34.10M | -52.43M | 83.40M |
| Investing Cash Flow | -34.59M | -40.42M | -14.94M | -16.65M | -3.88M | -6.49M |
| Financing Cash Flow | -72.99M | -17.63M | -11.72M | -19.27M | 55.38M | -71.43M |
Globrands Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:GLRS, the sentiment is Neutral. The current price of 10450.00 is above the 20-day moving average (MA) of 9408.55, above the 50-day MA of 9821.20, and below the 200-day MA of 21010.39, indicating a neutral trend. The MACD of 186.63 indicates Negative momentum. The RSI at 69.45 is Neutral, neither overbought nor oversold. The STOCH value of 92.91 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IL:GLRS.
Globrands Peers Comparison
Overall Rating
IL:TTAM70Outperform
IL:SAE63Neutral
IL:RMLI60Neutral
IL:YHNF60Neutral
IL:GLRS43Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 70Outperform | ILS 1.29B | 15.18 | ― | 1.96% | 13.15% | 34.98% | |
| 63Neutral | ILS 8.80B | 13.25 | 17.20% | 6.86% | -4.71% | -11.84% | |
| 60Neutral | ILS 4.45B | 20.26 | ― | 4.34% | 6.69% | -3.00% | |
| 60Neutral | ILS 4.67B | 23.19 | ― | 2.08% | 5.52% | 0.69% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 43Neutral | ILS 130.88M | 2.18 | ― | 31.11% | 6.09% | -13.79% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IL:GLRS | Globrands Group Ltd. | 10450.00 | -38454.34 | -78.63% | |
| IL:SAE | Shufersal Class B | 3180.00 | -879.22 | -21.66% | |
| IL:SANO1 | Sano-Brunos Enterprises Ltd. | 32500.00 | -8802.44 | -21.31% | |
| IL:TTAM | Tiv Taam Holdings 1 Ltd. | 1213.00 | 271.25 | 28.80% | |
| IL:RMLI | Rami Levi Chain Stores Hashikma Marketing 2006 Ltd | 31690.00 | -564.71 | -1.75% | |
| IL:YHNF | M. Yochananof & Sons (1988) Ltd. | 31650.00 | 2791.84 | 9.67% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 04, 2025
